BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30302596)

  • 1. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment.
    Gao YL; Jia XX; Wang M; Hua Y; Zheng H; Xiang WZ; Song XZ
    Lasers Med Sci; 2019 Jun; 34(4):767-771. PubMed ID: 30302596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study.
    Zhou Y; Li Y; Hamblin MR; Wen X
    Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ex vivo melanogenic response to UVB, UVA, and visible light in facial melasma and unaffected adjacent skin.
    Alcantara GP; Esposito ACC; Olivatti TOF; Yoshida MM; Miot HA
    An Bras Dermatol; 2020; 95(6):684-690. PubMed ID: 33010989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience using 675 nm laser on three cases of Fitzpatrick skin type IV-V with melasma.
    Pamela RD; Vitale MD; Fusco I; Zingoni T; Yi KH
    Skin Res Technol; 2024 May; 30(5):e13748. PubMed ID: 38766988
    [No Abstract]   [Full Text] [Related]  

  • 5. Melasma: Updates and perspectives.
    Kwon SH; Na JI; Choi JY; Park KC
    Exp Dermatol; 2019 Jun; 28(6):704-708. PubMed ID: 30422338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.
    Kung KY; Shek SY; Yeung CK; Chan HH
    Lasers Surg Med; 2019 Jan; 51(1):14-22. PubMed ID: 30357871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma.
    Lyons AB; Moy RL; Herrmann JL
    J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future therapies in melasma: What lies ahead?
    Sarkar R; Bansal A; Ailawadi P
    Indian J Dermatol Venereol Leprol; 2020; 86(1):8-17. PubMed ID: 31793496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Insights in Melasma and Hyperpigmentation Management.
    Huerth KA; Hassan S; Callender VD
    J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies.
    Rajanala S; Maymone MBC; Vashi NA
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
    Spierings NMK
    J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study on the use of a non-crosslinked hyaluronic acid with associated anti-oxidant ingredients to improve the effectiveness of Nd:YAG laser toning in the treatment of melasma in six patients.
    Yip DL
    J Cosmet Dermatol; 2020 Sep; 19(9):2212-2218. PubMed ID: 32585755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical Applications for Medical and Aesthetic Treatment of Skin of Color With a New 650-Microsecond Laser.
    Burgess C; Chilukuri S; Campbell-Chambers DA; Henry M; Saedi N; Roberts WE
    J Drugs Dermatol; 2019 Apr; 18(4):s138 - 143. PubMed ID: 31026130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser Treatment of Skin of Color for Medical and Aesthetic Uses With a New 650-Microsecond Nd:YAG 1064nm Laser.
    Roberts WE; Henry M; Burgess C; Saedi N; Chilukuri S; Campbell-Chambers DA
    J Drugs Dermatol; 2019 Apr; 18(4):s135-137. PubMed ID: 31017752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melasma Treatment: An Evidence-Based Review.
    McKesey J; Tovar-Garza A; Pandya AG
    Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical & ultrastructural evaluation of the effect of fractional CO2 laser on facial melasma.
    El-Sinbawy ZG; Abdelnabi NM; Sarhan NE; Elgarhy LH
    Ultrastruct Pathol; 2019; 43(4-5):135-144. PubMed ID: 31575311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser and laser compound therapy for melasma: a meta-analysis.
    Zhang Y; Zheng X; Chen Z; Lu L
    J Dermatolog Treat; 2020 Feb; 31(1):77-83. PubMed ID: 30702958
    [No Abstract]   [Full Text] [Related]  

  • 18. Laser Toning in Melasma.
    Shah SD; Aurangabadkar SJ
    J Cutan Aesthet Surg; 2019; 12(2):76-84. PubMed ID: 31413475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma.
    Xu J; Lu H; Luo H; Hu Y; Chen Y; Xie B; Du X; Hua Y; Song X
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1105-1111. PubMed ID: 33974351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Refractory Melasma in Asians With the Picosecond Alexandrite Laser.
    Polnikorn N; Tanghetti E
    Dermatol Surg; 2020 Dec; 46(12):1651-1656. PubMed ID: 32932271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.